EU regulation lacks consideration of pharmaceutical industry emissions
E&T
JANUARY 9, 2023
The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. Moreover, in the EU, it is not possible to refuse the marketing authorisation of human pharmaceuticals based on environmental reasons.
Let's personalize your content